Bladder Cancer Academy

	Why LUGPA Embraces Managing Advanced Genitourinary Cancers Neal Shore, MD, FACS
	Medical Director, Certified Physician Investigator Carolina Urologic Research Center Atlantic Urology Clinics

	Bladder Cancer Biomarkers: New and Old Michael Cookson, MD
	Professor & Chairman, Department of Urology The University of Oklahoma Health Sciences Center

	AUA Guidelines: Non-muscle Invasive Bladder Cancer Sam Chang, MD
	Professor of Urologic Surgery and Oncology Vanderbilt University Medical Center

	Intravesical Therapy: When Bacillus Calmette-Guerin Fails Noah Hahn, MD
	Associate Professor of Oncology and Urology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Director, Bladder Cancer Medical Oncology Program

	Bladder-sparing Strategies Trinity Bivalacqua, MD, PhD
	Director of Urology Oncology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Johns Hopkins Medical Institutions

	Immunotherapy for Advanced Bladder Cancer: The Next Frontier Arjun Balar, MD
	Assistant Professor, Department of Medicine Director, Genitourinary Medical Oncology Program NYU Langone Medical Center

	Targeted Therapies for Renal Cell Carcinoma Won Kim, MD
	Assistant Professor of Medicine and Urology Helen Diller Family Comprehensive Cancer Center University of California, San Francisco

	Immunotherapy of Renal Cell Carcinoma Hans Hammers, MD, PhD
	Associate Professor, Internal Medicine Division of Hematology and Oncology UT Southwestern – Kidney Cancer Program

	Genitourinary Oncology: A Peek Over the Horizon Dan Theodorescu, MD, PhD
	Paul A. Bunn, Jr. Endowed Chair in Cancer Research Professor of Surgery and Pharmacology Director, University of Colorado Cancer Center